论文部分内容阅读
目的:对现有人工流产术前用药作进一步的临床研究,以期最大程度地减轻受术者的痛苦。方法:将210例要求行人工流产术的早孕妇女随机分为联合治疗组、利多卡因组和米非司酮组,比较每组术中宫颈软化程度、人工流产综合征反应、手术时间及出血量。结果:联合治疗组在宫颈充分软化和降低人工流产综合征反应方面均表现出了优越性(P<0.05),在手术时间和出血量方面与其他两组无差异(P>0.05)。结论:人工流产术前联合应用利多卡因和米非司酮可以在很大程度上减轻患者的痛苦,从经济和精神方面大大减轻患者的负担。
OBJECTIVE: To conduct further clinical studies on the use of pre-abortion medications in order to minimize the pain of the affected person. Methods: A total of 210 early pregnant women who requested abortion were randomly divided into combined treatment group, lidocaine group and mifepristone group. The degree of cervical softening, the response to induced abortion syndrome, the operation time and bleeding the amount. Results: The combined treatment group showed superiority in cervical softening and response to abortion syndrome (P <0.05), but no difference in operative time and bleeding volume between the two groups (P> 0.05). CONCLUSIONS: Preoperative abortion with lidocaine and mifepristone prior to surgery can greatly reduce the patient’s pain and economically and mentally reduce the patient’s burden.